Single monthly administration of the anti-progestagen Org 31710 in users of the 75 μg desogestrel progestagen-only pill: Effects on pituitary-ovarian activity

Human Reproduction

Volumn 15, Issue 3, 2000, Pages 629-636

  Van Heusden, A M ^a   Killick, S R ^b   Coelingh Bennink, H J T ^c   Fauser, B C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HULL   (United Kingdom)

^c NV ORGANON   (Netherlands)

Author keywords

Anti progestagen; Contraception; Endometrium; Pituitary ovarian activity; Progestagen only contraception

Indexed keywords

11BETA [4 (DIMETHYLAMINO)PHENYL] 4',5' DIHYDRO 6BETA METHYLSPIRO[ESTRA 4,9 DIENE 17BETA,2'(3'H) FURAN] 3 ONE; DESOGESTREL; GESTAGEN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG COMPETITION; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MULTICENTER STUDY; NORMAL HUMAN; OVARY FOLLICLE DEVELOPMENT; OVULATION; PHASE 2 CLINICAL TRIAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0034052080     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.3.629     Document Type: Article

References (35)

1. Baird, D.T., Thong, K.J., Hall, C. and Cameron, S.T. (1995) Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days. Hum. Reprod., 10, 2270-2276.
2. Batista, M.C., Bristow, T.L., Mathews, J. et al. (1991) Daily administration of the progesterone antagonist RU 486 prevents implantation in the cycling guinea pig. Am. J. Obstet. Gynecol., 165, 82-86.
3. Batista, M.C., Cartledge, T.P., Zellmer, A.W. et al. (1992) Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: A potential new contraceptive strategy. Am. J. Obstet. Gynecol., 167, 60-65.
4. Belsey, E.M. (1988) The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception, 38, 207-225.
5. Broome, M. and Fotherby, K. (1990) Clinical experience with the progestogen-only pill. Contraception, 42, 489-495.
6. Darney, P.D., Taylor, R.N., Klaisle, C. et al. (1996) Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant registered implant users. Contraception, 53, 97-100.
7. De Jong, F.H., Baird, D.T. and van der Molen, H. (1974) Ovarian secretion rates of oestrogens, androgens and progesterone in normal women and in women with persistent ovarian follicles. Acta Endocrinology, 77, 3-87.
8. Heikinheimo, O., Gordon, K., Williams, R.F. and Hodgen, G.D. (1996) Inhibition of ovulation by progestin analogs (agonists versus antagonists): preliminary evidence for different sites and mechanisms of actions. Contraception, 53, 55-64.
9. Hemrika, D.J. (1993) Hypothalamic-pituitary-ovarian dynamics in oral contraceptive users. Thesis, Amsterdam.
10. Hild-Petito, S., Stouffer, R.L. and Brenner, R.M. (1988) Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology, 123, 2896-2905.
11. Hodgen, G.D., Van Uem, J.F.H.M., Chillik, C.F. et al. (1994) Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum. Reprod., 9, 77-81.
12. Ishwad, P.C., Katkam, R.R., Hinduja, I.N. et al. (1993) Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys. Contraception, 48, 57-70.
13. Kekkonen, R., Croxatto, H.B., Lahteenmaki, P. et al. (1995) Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation. Hum. Reprod., 10, 287-292.
14. Kim Bjorklund, T., Landgren, B. and Hamberger, L. (1992) Is the contraceptive effect of 300 mcg of norethisterone mainly peripheral or central? Contraception, 45, 57-66.
15. Kim Bjorklund, T., Landgren, B.M. and Johannisson, E. (1991) Morphometric studies of the endometrium, the Fallopian tube and the corpus luteum during contraception with the 300 mcg norethisterone (NET) minipill. Contraception, 43, 459-474.
16. Kloosterboer, H.J., Deckers, G.H. and Schoonen, W.J. (1994) Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806. Hum. Reprod., 9, 47-52.
17. Landgren, B.M. and Diczfalusy, E. (1980) Hormonal effects of the 300 mcg norethisterone (NET) minipill. 1. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception, 21, 87-113.
18. Landgren, B.M., Balogh, A., Shin, M.W. et al. (1979) Hormonal effects of the 300 meg norethisterone (NET) minipill. 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception, 20, 585-605.
19. Landgren, B.M., Aedo, A.R., Johannisson, E. and Cekan, S.Z. (1994) Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 mcg g/24 h: A pilot study. Contraception, 49, 139-150.
20. McCann, M.F.and Potter, L.S. (1994) Progestin-only oral contraception: A comprehensive review. Contraception, 50, S1-S198
21. Mizutani, T., Bhakta, A., Kloosterboer, H.J. and Moudgil, V.K. (1992) Novel antiprogestins Org 31806 and 31710: Interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes. J. Steroid Biochem. Mol. Biol., 42, 695-704.
22. Murphy, A.A., Kettel, L.M., Morales, A.J. et al. (1995) Endometrial effects of long-term low-dose administration of RU486. Fertil. Steril., 63, 761-766.
23. Neulen, J., Williams, R.F., Breckwoldt, M. et al. (1996) Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum. Reprod., 11, 1533-1537.
24. Pache, T.D., Wladimiroff, J.W., De Jong, F.H. et al. (1990) Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil. Steril., 54, 638-642.
25. Rice, C., Killick, S., Hickling, D. and Coelingh, B.H. (1996) Ovarian activity and vaginal bleeding patterns with a desogestrel-only preparation at three different doses. Hum. Reprod., 11, 737-740.
26. Shaaban, M.M., Segal, S., Salem, H.T. et al. (1993) Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Fertil. Steril., 59, 998-1002.
27. Shepard, M.K. and Senturia, Y.D. (1977) Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function. Fertil. Steril., 28, 5-8.
28. Shoupe, D., Horenstein, J., Mishell, D.R. et al. (1991) Characteristics of ovarian follicular development in Norplant users. Fertil. Steril., 55, 766-770.
29. Spitz, I.M., Croxatto, H.B., Salvatierra, A.M. and Heikinheimo, O. (1993) Response to intermittent RU486 in women. Fertil. Steril., 59, 971-975.
30. Tafurt, C.A., Sobrevilla, L.A. and De Estrada, R. (1980) Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids, and sex hormone-binding globulin. Fertil. Steril., 33, 261-266.
31. Tayob, Y., Guillebaud, J., Adams, J. and Jacobs, H.S. (1986) Studies on ovarian function in users of the progestagen only contraceptive pill. J. Obstet. Gynecol., 6, S91-S95
32. van Santbrink, E.J., Hop, W.C., van Dessel, H.J. et al. (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil. Steril., 64, 37-43.
33. Van Uem, J.F.H.M., Hsiu, J.G., Chillik, C.F. et al. (1989) Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception, 40, 171-184.
34. Wolf, J.P., Hsiu, J.G., Anderson, T.L. et al. (1989) Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril., 52, 1055-1060.
35. Zalanyi, S., Landgren, B. and Johannisson, E. (1984) Pharmacokinetics, pharmacodynamic and endometrial effects of a single dose of 200 mg norethisterone enanthate. Contraception, 30, 225-237.